Clinical Trial Update: Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rifabutin for Mycobacterium avium complex infection has completed, assessing its effectiveness in treating non-tuberculous mycobacter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Infection

Drugs mentioned

• Rifabutin (Mycobutin) (rifabutin)

Snippet

Sponsor: The University of Texas Health Science Center at Tyler | Conditions: Nontuberculous Mycobacterial Infections | Phase 3 | Status: COMPLETED